Webinar: Addressing the Unmet Need in Essential Tremor: Transcutaneous Afferent Patterned Stimulation (TAPS) Therapy
Access Updates: CMS and Evidence
Cala is excited to provide important updates such as the recently upgraded ECRI Evidence Assessment in our upcoming webinar for payors. Join us to learn about this and other exciting updates on Cala TAPS Therapy.
Join us for an educational program on solving the unmet need in essential tremor. Hear from Dr. Pravin Khemani, Medical Director of the Movement Disorders Program at the Swedish Neuroscience Institute, on February 16, 2023, at 12:00 PM PST.
The following topics will be covered:
- ECRI upgraded Evidence Assessment
- What is TAPS / Cala Trio for essential tremors?
- What is the clinical evidence to support it?
- Hear from a patient living with essential tremor and his experience with Cala Trio
Thursday, February 16, 2023, 3:00 pm ET / 12:00 pm PT
Speaker lineup
Pravin Khemani, M.D.
Swedish Neuroscience Institute
Dr. Khemani is the Medical Director of the Movement Disorders Program at the Swedish Neuroscience Institute. Dr. Khemani is a Movement Disorders Neurologist specializing in Parkinson’s Disease, Essential Tremor, Deep Brain Stimulation, Dystonia, and Ataxia. His clinical research consists of co-authoring 23 peer-reviewed articles, and is an active participant in clinical trials.
Dhira Khosla D.O.
Medical Director, Cala
Dr. Dhira Khosla currently serves as the Medical Director of Cala. She completed her neurology residency at SUNY Downstate and neuromuscular fellowship training at Stanford University. She is board certified by the American Board of Psychiatry and Neurology and has practiced for 13 years in a community-based setting. Her research interests lie in bioelectronic medicine and non-invasive medical devices to help patients suffering from neurological conditions.
Ben Duncan
Patient Ambassador, retired U.S. Air Force
Ben Duncan is retired from a 21-year Air Force career and secondary careers in county government and aircraft manufacturing. His ET developed in 2008 and progressed to requiring the maximum dose of three medications. In 2020, Mr. Duncan began using Cala Trio Therapy daily and it’s helped him manage tremor in his dominant hand. His healthcare team has weaned him off all medications.